These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22540301)

  • 1. Comparison of analytical and clinical performance of three methods for detection of Clostridium difficile.
    LaSala PR; Svensson AM; Mohammad AA; Perrotta PL
    Arch Pathol Lab Med; 2012 May; 136(5):527-31. PubMed ID: 22540301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.
    Snell H; Ramos M; Longo S; John M; Hussain Z
    J Clin Microbiol; 2004 Oct; 42(10):4863-5. PubMed ID: 15472364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile testing algorithms: what is practical and feasible?
    Schmidt ML; Gilligan PH
    Anaerobe; 2009 Dec; 15(6):270-3. PubMed ID: 19853666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
    Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
    Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple 3-step algorithm for improved laboratory detection of Clostridium difficile toxin without the need for tissue culture cytotoxicity neutralization assays.
    Sharp SE; Ivie WM; Buckles MR; Coover DM; Pohl JC; Hatcher PA
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):344-6. PubMed ID: 19376666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the VIDAS glutamate dehydrogenase assay for the detection of Clostridium difficile.
    Shin BM; Lee EJ; Moon JW; Lee SY
    Anaerobe; 2016 Aug; 40():68-72. PubMed ID: 27282799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new rapid method for Clostridium difficile DNA extraction and detection in stool: toward point-of-care diagnostic testing.
    Freifeld AG; Simonsen KA; Booth CS; Zhao X; Whitney SE; Karre T; Iwen PC; Viljoen HJ
    J Mol Diagn; 2012; 14(3):274-9. PubMed ID: 22402170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new immunochromatography test for rapid and simultaneous detection of Clostridium difficile antigen and toxins.
    Samra Z; Madar-Shapiro L; Aziz M; Bishara J
    Isr Med Assoc J; 2013 Jul; 15(7):373-6. PubMed ID: 23943984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
    Chan EL; Seales D; Drum H
    Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with laboratory diagnosis of Clostridium difficile].
    Bareková L; Zálabská E; Hanovcová I
    Klin Mikrobiol Infekc Lek; 2013 Sep; 19(3):91-5. PubMed ID: 24579451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory comparison between cell cytotoxicity neutralization assay and ultrasensitive single molecule counting technology for detection of Clostridioides difficile toxins A and B, PCR, enzyme immunoassays, and multistep algorithms.
    Sandlund J; Mills R; Griego-Fullbright C; Wagner A; Estis J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Nolan N; Bishop JJ; Todd J; Young S
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):20-24. PubMed ID: 31129008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
    Nurzyńska G; Pituch H; Kamola R; Kopeć ES
    Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
    Shin BM; Lee EJ; Kuak EY; Yoo SJ
    Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A.
    Gilligan PH; Walden TP; Kelly WF; Wait KJ; Kraft JA; Willis DH
    Arch Pathol Lab Med; 1993 May; 117(5):507-10. PubMed ID: 8489340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.
    Mattner F; Winterfeld I; Mattner L
    Scand J Infect Dis; 2012 Aug; 44(8):578-85. PubMed ID: 22404319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New methodological advances: algorithm proposal for management of Clostridium difficile infection].
    González-Abad MJ; Alonso-Sanz M
    Rev Esp Quimioter; 2015 Jun; 28(3):157-9. PubMed ID: 26033001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.
    Massey V; Gregson DB; Chagla AH; Storey M; John MA; Hussain Z
    Am J Clin Pathol; 2003 Jan; 119(1):45-9. PubMed ID: 12520696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of three enzyme immunoassays for detection of Clostridium difficile toxins A and B].
    Ould-Hocine ZF; Djibo N; Deforges L; Legrand P; Cattoir V
    Pathol Biol (Paris); 2008; 56(7-8):424-8. PubMed ID: 18824307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.